Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Clinical trial NCT01763450 · UNKNOWN

Trial details

NCT number: NCT01763450
Sponsor: Liaoning Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Metastases Colorectal Cancer

Start date: 2012-09-01
Primary completion: 2013-05-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.